Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lyra Therapeutics (LYRA) Restructuring Costs (2024 - 2025)

Historic Restructuring Costs for Lyra Therapeutics (LYRA) over the last 2 years, with Q3 2025 value amounting to -$21000.0.

  • Lyra Therapeutics' Restructuring Costs fell 10074.89% to -$21000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $10.9 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Lyra Therapeutics reported Restructuring Costs of -$21000.0 as of Q3 2025, which was down 10074.89% from $400000.0 recorded in Q2 2025.
  • Lyra Therapeutics' Restructuring Costs' 5-year high stood at $6.4 million during Q2 2024, with a 5-year trough of -$21000.0 in Q3 2025.